Ariana Boswell

All articles by Ariana Boswell

• Obesity linked to poorer response to pembrolizumab in endometrial cancer

  A study found that progression-free survival, but not overall survival, was worse among obese patients with EC treated with pembrolizumab.

• Review: Metabolic changes may signal risk of endometrial cancer

  Although EC is strongly linked with obesity, other factors including metabolic instability should also be considered, a recent study found.

• What you should know about immunotherapy for endometrial cancer

  Immunotherapy overrides the cancer cells’ defenses, allowing your immune system to attack the EC cells.

• Tips for staying hydrated during endometrial cancer treatment

  Learn how to increase your fluid intake and maintain your electrolyte balance during endometrial cancer treatment.

• Study suggests link between dairy consumption and endometrial cancer risk

  Researchers asked patients with EC and controls about their eating habits, finding that cases had lower average dairy consumption.

• Reduced lenvatinib dose for EC improves safety but lowers efficacy

  Lower lenvatinib doses are often used to prevent side effects in patients with advanced EC, but this could lead to worse survival outcomes.

• Potential EC therapy receives Breakthrough Therapy Designation from FDA

  Rina-S is a novel therapy designed for patients with endometrial cancer who do not respond to platinum-based therapies of PD-L1 immunotherapy.

• Fertility preservation options for women with endometrial cancer

  An endometrial cancer diagnosis doesn’t necessarily mean you can’t have children in the future.

• Surgical menopause: What to expect after ovary removal

  Surgical menopause causes the same symptoms as natural menopause, but they may be felt more strongly.

• Depression, anxiety linked to higher mortality rate in endometrial cancer

  A study of patients with EC and other gynecological cancers found that those with depression and anxiety had higher mortality rates.